Market Closed -
Other stock markets
|
After hours 20:55:35 | |||
84.75 EUR | +2.79% |
|
85.02 | +0.32% |
07-08 | KNORR-BREMSE : UBS remains its Buy rating | ZD |
07-02 | KNORR-BREMSE : Warburg Research gives a Neutral rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.38 | 7.68 | 6.02 | 6.76 | 5.66 | |||||
Return on Total Capital | 13.33 | 14.04 | 10.56 | 11.35 | 8.98 | |||||
Return On Equity % | 27.84 | 29.78 | 19.79 | 20.83 | 15.82 | |||||
Return on Common Equity | 27.41 | 29.88 | 19.95 | 20.47 | 15.13 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.82 | 49.5 | 46.99 | 48.34 | 51.38 | |||||
SG&A Margin | 24.72 | 24.28 | 25.04 | 24.77 | 25.7 | |||||
EBITDA Margin % | 16.34 | 15.87 | 12.67 | 13.43 | 12.71 | |||||
EBITA Margin % | 13.74 | 13.41 | 10.33 | 11.26 | 10.36 | |||||
EBIT Margin % | 13.49 | 13.2 | 10.1 | 11.03 | 10.12 | |||||
Income From Continuing Operations Margin % | 8.54 | 9.54 | 6.98 | 7.17 | 5.97 | |||||
Net Income Margin % | 7.95 | 9.15 | 6.72 | 6.87 | 5.57 | |||||
Net Avail. For Common Margin % | 7.95 | 9.15 | 6.72 | 6.87 | 5.57 | |||||
Normalized Net Income Margin | 7.17 | 7.68 | 5.88 | 5.95 | 5.21 | |||||
Levered Free Cash Flow Margin | 7.81 | 5.23 | -3.63 | 3.54 | 6.65 | |||||
Unlevered Free Cash Flow Margin | 8.48 | 5.75 | -3.2 | 4.32 | 7.49 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.88 | 0.93 | 0.95 | 0.98 | 0.9 | |||||
Fixed Assets Turnover | 4.8 | 4.74 | 4.64 | 5.01 | 4.86 | |||||
Receivables Turnover (Average Receivables) | 5.06 | 5.37 | 5.34 | 5.64 | 5.36 | |||||
Inventory Turnover (Average Inventory) | 3.69 | 3.71 | 3.59 | 3.64 | 3.3 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.32 | 1.46 | 1.65 | 1.75 | 1.63 | |||||
Quick Ratio | 1.03 | 1.04 | 1.1 | 1.14 | 1.17 | |||||
Operating Cash Flow to Current Liabilities | 0.3 | 0.36 | 0.2 | 0.35 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 72.35 | 68.03 | 68.38 | 64.69 | 68.22 | |||||
Days Outstanding Inventory (Average Inventory) | 99.07 | 98.31 | 101.75 | 100.38 | 110.99 | |||||
Average Days Payable Outstanding | 117.96 | 111.65 | 108.99 | 106.14 | 107.62 | |||||
Cash Conversion Cycle (Average Days) | 53.46 | 54.69 | 61.14 | 58.93 | 71.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 116.69 | 57.25 | 80.67 | 70.91 | 101.5 | |||||
Total Debt / Total Capital | 53.85 | 36.41 | 44.65 | 41.49 | 50.37 | |||||
LT Debt/Equity | 57.71 | 50.71 | 70.74 | 65.37 | 70.67 | |||||
Long-Term Debt / Total Capital | 26.63 | 32.25 | 39.16 | 38.25 | 35.07 | |||||
Total Liabilities / Total Assets | 74 | 66.31 | 66.41 | 64.8 | 67.47 | |||||
EBIT / Interest Expense | 12.59 | 15.86 | 14.42 | 8.77 | 7.56 | |||||
EBITDA / Interest Expense | 16.08 | 20.11 | 19.36 | 11.36 | 10.17 | |||||
(EBITDA - Capex) / Interest Expense | 12.46 | 15.47 | 14.89 | 8.85 | 8.04 | |||||
Total Debt / EBITDA | 2.09 | 1.22 | 2.21 | 1.79 | 2.92 | |||||
Net Debt / EBITDA | -0.03 | 0.01 | 0.84 | 0.67 | 0.84 | |||||
Total Debt / (EBITDA - Capex) | 2.69 | 1.59 | 2.87 | 2.3 | 3.69 | |||||
Net Debt / (EBITDA - Capex) | -0.04 | 0.01 | 1.09 | 0.86 | 1.06 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -11.08 | 8.92 | 6.86 | 10.81 | -0.53 | |||||
Gross Profit, 1 Yr. Growth % | -9 | 6.1 | 1.45 | 13.98 | 5.71 | |||||
EBITDA, 1 Yr. Growth % | -16.15 | 6.08 | -14.61 | 17.79 | -0.1 | |||||
EBITA, 1 Yr. Growth % | -19.43 | 6.68 | -17.65 | 21.24 | -1.78 | |||||
EBIT, 1 Yr. Growth % | -19.58 | 6.91 | -18.14 | 21.33 | -1.82 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -15.8 | 21.65 | -21.8 | 13.82 | -17.19 | |||||
Net Income, 1 Yr. Growth % | -15.79 | 25.39 | -21.51 | 12.93 | -19.53 | |||||
Normalized Net Income, 1 Yr. Growth % | -20.74 | 17.16 | -18.08 | 12.58 | -12.17 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -15.89 | 25.41 | -21.42 | 13.12 | -19.53 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.09 | 6.52 | 8.24 | 1.69 | 7.59 | |||||
Inventory, 1 Yr. Growth % | 3.63 | 18.66 | 13.95 | 0.03 | 6.48 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.27 | 16.82 | 2.48 | 2.89 | 2.4 | |||||
Total Assets, 1 Yr. Growth % | 7.93 | -2.58 | 11.29 | 1.31 | 16.55 | |||||
Tangible Book Value, 1 Yr. Growth % | -4.64 | 39.67 | -10.43 | 24.15 | -10.29 | |||||
Common Equity, 1 Yr. Growth % | 2.59 | 27.19 | 10.03 | 10.64 | 7.37 | |||||
Cash From Operations, 1 Yr. Growth % | 5.09 | -5.84 | -44.48 | 68.88 | 13.88 | |||||
Capital Expenditures, 1 Yr. Growth % | 9.56 | 8.52 | -13.16 | 11.75 | -10.24 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -18.48 | -26.83 | -174.38 | -214.67 | 205.47 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -17.74 | -25.93 | -159.49 | -260.61 | 152.37 | |||||
Dividend Per Share, 1 Yr. Growth % | -15.56 | 21.71 | -21.62 | 13.1 | 6.71 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.29 | -1.59 | 7.89 | 8.82 | 4.98 | |||||
Gross Profit, 2 Yr. CAGR % | -1.75 | -1.74 | 3.75 | 7.54 | 9.77 | |||||
EBITDA, 2 Yr. CAGR % | -6.92 | -5.82 | -4.86 | 0.15 | 5.28 | |||||
EBITA, 2 Yr. CAGR % | -8.81 | -7.45 | -6.31 | -0.24 | 5.3 | |||||
EBIT, 2 Yr. CAGR % | -7.77 | -7.43 | -6.49 | -0.5 | 5.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -8.05 | 1.21 | -2.47 | -5.66 | -2.93 | |||||
Net Income, 2 Yr. CAGR % | -8.57 | 2.76 | -0.79 | -5.7 | -4.63 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.39 | -3.82 | -2.08 | -4.16 | -0.96 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -8.63 | 2.7 | -0.73 | -5.65 | -4.56 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.25 | 2.64 | 7.38 | 4.91 | 4.57 | |||||
Inventory, 2 Yr. CAGR % | 0.49 | 10.89 | 16.28 | 6.76 | 3.19 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 15.3 | 9.84 | 9.42 | 2.69 | 2.62 | |||||
Total Assets, 2 Yr. CAGR % | 8.63 | 2.54 | 4.12 | 7.04 | 8.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.99 | 15.41 | 11.85 | -0.02 | 5.55 | |||||
Common Equity, 2 Yr. CAGR % | 10.4 | 14.23 | 18.3 | 10.36 | 9 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.5 | -0.52 | -27.7 | -3.17 | 38.71 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.43 | 9.04 | -2.92 | -1.49 | 0.13 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.43 | -22.91 | -26.28 | -10.44 | 46.46 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 21.38 | -22.07 | -33.66 | -5.59 | 66.36 | |||||
Dividend Per Share, 2 Yr. CAGR % | -6.8 | 1.38 | -2.33 | -5.85 | 9.86 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.26 | 0.62 | 1.15 | 8.85 | 5.61 | |||||
Gross Profit, 3 Yr. CAGR % | 0.61 | 0.8 | -0.69 | 7.05 | 6.93 | |||||
EBITDA, 3 Yr. CAGR % | -2.07 | -2.86 | -8.87 | 2.07 | -1.91 | |||||
EBITA, 3 Yr. CAGR % | -3.11 | -4.02 | -11.01 | 1.98 | -3.09 | |||||
EBIT, 3 Yr. CAGR % | -2.16 | -3.23 | -11.17 | 1.88 | -3.32 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -3.23 | 0.94 | -7.13 | 2.69 | -9.68 | |||||
Net Income, 3 Yr. CAGR % | -2.55 | 1.58 | -6.07 | 3.7 | -10.53 | |||||
Normalized Net Income, 3 Yr. CAGR % | -2.19 | 0.03 | -8.86 | 2.44 | -7.16 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.58 | 1.54 | -6.07 | 3.74 | -10.5 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.03 | -0.79 | 4.48 | 5.45 | 5.78 | |||||
Inventory, 3 Yr. CAGR % | 4.09 | 6.22 | 11.9 | 10.59 | 6.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.62 | 15.8 | 7.33 | 7.2 | 2.57 | |||||
Total Assets, 3 Yr. CAGR % | 8.87 | 4.76 | 5.38 | 3.73 | 10.12 | |||||
Tangible Book Value, 3 Yr. CAGR % | -9.25 | 13.26 | 6.06 | 11.77 | -3.56 | |||||
Common Equity, 3 Yr. CAGR % | -0.31 | 15.74 | 12.81 | 15.71 | 9.36 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.07 | 10.37 | -18.1 | -4.07 | 2.22 | |||||
Capital Expenditures, 3 Yr. CAGR % | 9.33 | 4.42 | 1.07 | 1.74 | -4.51 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 21.73 | 3 | -23.86 | -16.32 | 14.48 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.58 | 2.84 | -28.81 | -12.96 | 15.38 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 1.87 | -6.95 | 2.57 | -1.84 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.34 | 4.32 | 3.24 | 3.82 | 2.67 | |||||
Gross Profit, 5 Yr. CAGR % | 0.66 | 2.8 | 1.86 | 3.44 | 3.37 | |||||
EBITDA, 5 Yr. CAGR % | -3.25 | 1.29 | -3.25 | -1.68 | -3.51 | |||||
EBITA, 5 Yr. CAGR % | -3.53 | 1.85 | -4.46 | -2.54 | -4.87 | |||||
EBIT, 5 Yr. CAGR % | -3.87 | 1.53 | -3.98 | -2.16 | -5 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.77 | 3.33 | -2.92 | -1.75 | -5.47 | |||||
Net Income, 5 Yr. CAGR % | -2.7 | 5.09 | -1.85 | -1.4 | -5.43 | |||||
Normalized Net Income, 5 Yr. CAGR % | -4.12 | 3.21 | -2.22 | -1.69 | -5.86 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.73 | 5.06 | -1.84 | -1.4 | -5.44 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.45 | 6.31 | 2.25 | 1.45 | 4.52 | |||||
Inventory, 5 Yr. CAGR % | 15.12 | 19.03 | 8.81 | 6.43 | 8.33 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.09 | 14.68 | 9.54 | 10.37 | 5.42 | |||||
Total Assets, 5 Yr. CAGR % | 13.05 | 9.35 | 6.94 | 5.66 | 7.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | -6.11 | -0.09 | -1.34 | 7.75 | 3.62 | |||||
Common Equity, 5 Yr. CAGR % | 3.77 | 7.5 | 6.75 | 13.56 | 11.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 2.57 | 6.58 | -4.45 | 4.74 | 1.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.06 | 8.58 | 4.25 | 2.01 | 0.69 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.32 | -5.63 | -0.47 | -2.63 | -2.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -4.9 | -3.97 | -4.65 | -0.64 | -1.41 | |||||
Dividend Per Share, 5 Yr. CAGR % | -7.61 | -3.91 | - | -1.29 | -0.56 |
- Stock Market
- Equities
- KBX Stock
- Financials Knorr-Bremse AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition